JP2013527197A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013527197A5 JP2013527197A5 JP2013512249A JP2013512249A JP2013527197A5 JP 2013527197 A5 JP2013527197 A5 JP 2013527197A5 JP 2013512249 A JP2013512249 A JP 2013512249A JP 2013512249 A JP2013512249 A JP 2013512249A JP 2013527197 A5 JP2013527197 A5 JP 2013527197A5
- Authority
- JP
- Japan
- Prior art keywords
- matrix
- self
- adhesive
- item
- piroxicam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39634710P | 2010-05-27 | 2010-05-27 | |
| US61/396,347 | 2010-05-27 | ||
| PCT/US2011/038189 WO2011150239A2 (en) | 2010-05-27 | 2011-05-26 | Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015235438A Division JP2016033163A (ja) | 2010-05-27 | 2015-12-02 | ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013527197A JP2013527197A (ja) | 2013-06-27 |
| JP2013527197A5 true JP2013527197A5 (enExample) | 2014-07-10 |
| JP5948322B2 JP5948322B2 (ja) | 2016-07-06 |
Family
ID=44352274
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013512249A Expired - Fee Related JP5948322B2 (ja) | 2010-05-27 | 2011-05-26 | ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法 |
| JP2015235438A Pending JP2016033163A (ja) | 2010-05-27 | 2015-12-02 | ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015235438A Pending JP2016033163A (ja) | 2010-05-27 | 2015-12-02 | ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8563031B2 (enExample) |
| EP (1) | EP2575791B1 (enExample) |
| JP (2) | JP5948322B2 (enExample) |
| CN (1) | CN102970986B (enExample) |
| AU (1) | AU2011258146A1 (enExample) |
| CA (1) | CA2800716C (enExample) |
| WO (1) | WO2011150239A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3054931B1 (en) * | 2013-10-07 | 2020-12-23 | Teikoku Pharma USA, Inc. | Transdermal delivery device for managing pain comprising dexmedetomidine transdermal compositions |
| CN107028921A (zh) * | 2017-05-16 | 2017-08-11 | 蔡志浩 | 一种吡罗昔康巴布贴剂 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5989586A (en) | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
| JP2847578B2 (ja) | 1992-12-31 | 1999-01-20 | スンキョン インダストリイズ カンパニイ リミテッド | 皮膚浸透力を高めた医薬組成物 |
| AU6635294A (en) | 1993-04-22 | 1994-11-08 | Minnesota Mining And Manufacturing Company | Transdermal antiinflammatory composition |
| DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
| JP3305101B2 (ja) * | 1994-03-29 | 2002-07-22 | 積水化学工業株式会社 | 経皮吸収製剤 |
| JPH08295624A (ja) * | 1995-04-26 | 1996-11-12 | Read Chem Kk | プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤 |
| KR100294084B1 (ko) * | 1998-06-02 | 2001-09-22 | 성재갑 | 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형 |
| WO2001039753A1 (de) * | 1999-11-29 | 2001-06-07 | Lts Lohmann Therapie-Systeme Ag | Transdermale therapeutische systeme mit verbesserter stabilität und ein verfahren zu ihrer herstellung |
| US6645520B2 (en) * | 1999-12-16 | 2003-11-11 | Dermatrends, Inc. | Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers |
| ES2559666T3 (es) | 2001-03-07 | 2016-02-15 | Hisamitsu Pharmaceutical Co., Inc. | Parche adhesivo |
| US20050020658A1 (en) * | 2002-11-21 | 2005-01-27 | Katsuyuki Inoo | Selective cyclooxygenase-2 inhibitor patch |
| US20040127531A1 (en) * | 2002-11-21 | 2004-07-01 | Lu Guang Wei | Adhesive coated sheet for dermal delivery of a selective cyclooxygenase-2 inhibitor |
| KR100552650B1 (ko) * | 2003-11-17 | 2006-02-20 | 아이큐어 주식회사 | 피록시캄 함유 소염진통용 플라스터 |
| AU2004290464A1 (en) * | 2003-11-19 | 2005-06-02 | Acrux Dds Pty Ltd | Method and composition for treatment or prophylaxis of amyloidosis disorders |
| US20070196457A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs |
| DE102004062614B4 (de) * | 2004-12-24 | 2011-12-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung |
| US20080226698A1 (en) * | 2007-03-16 | 2008-09-18 | Mylan Technologies, Inc. | Amorphous drug transdermal systems, manufacturing methods, and stabilization |
| EP2676680A1 (de) * | 2007-09-13 | 2013-12-25 | Basf Se | Verwendung von Hydrophobin-Polipeptiden als Penetrationsverstärker |
-
2011
- 2011-05-25 US US13/115,898 patent/US8563031B2/en not_active Expired - Fee Related
- 2011-05-26 EP EP11727855.6A patent/EP2575791B1/en not_active Not-in-force
- 2011-05-26 WO PCT/US2011/038189 patent/WO2011150239A2/en not_active Ceased
- 2011-05-26 CN CN201180031485.5A patent/CN102970986B/zh active Active
- 2011-05-26 CA CA2800716A patent/CA2800716C/en not_active Expired - Fee Related
- 2011-05-26 JP JP2013512249A patent/JP5948322B2/ja not_active Expired - Fee Related
- 2011-05-26 AU AU2011258146A patent/AU2011258146A1/en not_active Abandoned
-
2013
- 2013-10-21 US US14/059,375 patent/US20140046274A1/en not_active Abandoned
-
2015
- 2015-12-02 JP JP2015235438A patent/JP2016033163A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Durand et al. | Practical considerations for optimal transdermal drug delivery | |
| PH12015501169A1 (en) | Transdermal delivery system | |
| PH12015502550A1 (en) | Transdermal delivery system | |
| PH12014501231A1 (en) | Transdermal delivery system comprising buprenorphine | |
| JP2018518498A5 (enExample) | ||
| MX382132B (es) | Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno | |
| JP2016502989A5 (enExample) | ||
| MY183873A (en) | Transdermal therapeutic system for application of an agent | |
| JP2016504368A5 (enExample) | ||
| JP2008504869A (ja) | 身体に治療をもたらすためのシステム及び方法 | |
| MX2009014102A (es) | Sistema de administración transdérmica que comprende glicopirrolato para tratar sialorrea. | |
| WO2008027203A2 (en) | Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue | |
| EA201300648A1 (ru) | Трансдермальная терапевтическая система (tts), содержащая ротиготин | |
| CN1950074A (zh) | 用于为身体的部位提供治疗的具有彼此可拆卸地固定在一起的两个贴片的皮肤系统 | |
| WO2016149077A3 (en) | Fentanyl transdermal delivery system | |
| JP2013527197A5 (enExample) | ||
| CN108697658B (zh) | 贴剂 | |
| MX2015010967A (es) | Formulaciones transdermicas de laquinimod. | |
| JP2018537451A5 (enExample) | ||
| JP5948322B2 (ja) | ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法 | |
| JP2003327527A (ja) | 発熱体積層経皮投与製剤 | |
| WO2024189213A1 (en) | Medical patch comprising skin irritating active agent | |
| JP2011510936A5 (enExample) | ||
| JP2004315542A (ja) | 外用貼付剤及び外用貼付剤中の薬物のエステル化抑制方法 | |
| WO2024189202A1 (en) | Medical patch comprising capsaicin |